Suggested Dosing
Drink at least 2 L of water qDay while taking goldenrod
Tea
One cup of tea BID-QID between meals
Seep 1-2 tsp (3-5 g) of the dried herb in 150 mL boiling water for 5-10 minutes, strain.
Usual dose ranges from 6-12 g/day
Liquid Extract (1:1 in 25% ethanol)
0.5-2 mL BID-TID
Tincute (1:5 in 45% ethanol)
0.5-1 mL BID-TID
Suggested Uses
Diuretic, anti-inflammatory, antispasmodic, gout, rheumatism, arthritis, eczema, acute pulmonary tuberculosis, diabetes, liver enlargement, hemorrhoids, internal bleeding, allergic rhinitis, asthma, prostatic hypertrophy,"irrigation therapy" to increase urine flow to treat/prevent inflammatory disease of the lower urinary tract, urinary calculi, and kidney gravel
Efficacy
Insufficient information available about effectiveness. More studies needed
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (16)
- amiloride
goldenrod increases effects of amiloride by pharmacodynamic synergism. Minor/Significance Unknown.
- bendroflumethiazide
goldenrod increases effects of bendroflumethiazide by pharmacodynamic synergism. Minor/Significance Unknown.
- bumetanide
goldenrod increases effects of bumetanide by pharmacodynamic synergism. Minor/Significance Unknown.
- chlorothiazide
goldenrod increases effects of chlorothiazide by pharmacodynamic synergism. Minor/Significance Unknown.
- chlorthalidone
goldenrod increases effects of chlorthalidone by pharmacodynamic synergism. Minor/Significance Unknown.
- cyclopenthiazide
goldenrod increases effects of cyclopenthiazide by pharmacodynamic synergism. Minor/Significance Unknown.
- drospirenone
goldenrod increases effects of drospirenone by pharmacodynamic synergism. Minor/Significance Unknown.
- ethacrynic acid
goldenrod increases effects of ethacrynic acid by pharmacodynamic synergism. Minor/Significance Unknown.
- furosemide
goldenrod increases effects of furosemide by pharmacodynamic synergism. Minor/Significance Unknown.
- hydrochlorothiazide
goldenrod increases effects of hydrochlorothiazide by pharmacodynamic synergism. Minor/Significance Unknown.
- indapamide
goldenrod increases effects of indapamide by pharmacodynamic synergism. Minor/Significance Unknown.
- methyclothiazide
goldenrod increases effects of methyclothiazide by pharmacodynamic synergism. Minor/Significance Unknown.
- metolazone
goldenrod increases effects of metolazone by pharmacodynamic synergism. Minor/Significance Unknown.
- spironolactone
goldenrod increases effects of spironolactone by pharmacodynamic synergism. Minor/Significance Unknown.
- torsemide
goldenrod increases effects of torsemide by pharmacodynamic synergism. Minor/Significance Unknown.
- triamterene
goldenrod increases effects of triamterene by pharmacodynamic synergism. Minor/Significance Unknown.
Adverse Effects
Allergic symptoms
Warnings
Contraindications
Pollen hypersensitivity
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Saponins, flavonoids have diuretic effect w/o Na+ loss
